BUSULFAN

BUSULFAN was reported 15927 times

BUSULFAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RHIZOBIUM RADIOBACTER BACTERAEMIA 13 0.8667
1 ACTINOMYCOTIC SEPSIS 18 0.7200
2 CYTOMEGALOVIRUS URINARY TRACT INFECTION 20 0.6452
3 SERTOLI-CELL-ONLY SYNDROME 9 0.6000
4 OVARIAN ATROPHY 27 0.3176
5 DONOR LEUKOCYTE INFUSION 8 0.3077
6 OVARIAN DYSFUNCTION 15 0.3000
7 VIRAL HAEMORRHAGIC CYSTITIS 205 0.2879
8 CYSTITIS VIRAL 99 0.2585
9 PRIMARY HYPOGONADISM 38 0.2420
10 DISSEMINATED TOXOPLASMOSIS 29 0.2417
11 AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME 14 0.2373
12 BRONCHIOLITIS OBLITERANS SYNDROME 39 0.2229
13 IDIOPATHIC PNEUMONIA SYNDROME 65 0.2181
14 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 599 0.2165
15 CHIMERISM 19 0.2135
16 VENOOCCLUSIVE DISEASE 533 0.2127
17 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 39 0.2053
18 RETINOPATHY HAEMORRHAGIC 13 0.1970
19 ENGRAFT FAILURE 55 0.1916
20 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 264 0.1868
21 ACUTE GRAFT VERSUS HOST DISEASE 832 0.1816
22 VENOOCCLUSIVE LIVER DISEASE 888 0.1796
23 HYPERFIBRINOGENAEMIA 12 0.1791
24 CHRONIC GRAFT VERSUS HOST DISEASE 645 0.1785
25 HEART FAILURE WITH MIDRANGE EJECTION FRACTION 10 0.1695
26 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 120 0.1669
27 VIRURIA 18 0.1667
28 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 354 0.1662
29 GRAFT VERSUS HOST DISEASE IN SKIN 366 0.1660
30 RETINITIS VIRAL 20 0.1653
31 IATROGENIC KAPOSI SARCOMA 8 0.1633
32 ELECTROCARDIOGRAM T WAVE BIPHASIC 9 0.1607
33 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 147 0.1587
34 STENOTROPHOMONAS BACTERAEMIA 12 0.1579
35 ENGRAFTMENT SYNDROME 93 0.1574
36 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 199 0.1511
37 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 30 0.1478
38 ARTERITIS INFECTIVE 9 0.1475
39 BONE MARROW TRANSPLANT REJECTION 31 0.1409
40 CYTOMEGALOVIRUS INFECTION REACTIVATION 619 0.1400
41 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 50 0.1374
42 UPPER RESPIRATORY FUNGAL INFECTION 26 0.1368
43 SHORT STATURE 34 0.1298
44 GRAFT VERSUS HOST DISEASE 922 0.1281
45 COMPLICATIONS OF BONE MARROW TRANSPLANT 46 0.1274
46 HERPES ZOSTER INFECTION NEUROLOGICAL 20 0.1258
47 PRE-ENGRAFTMENT IMMUNE REACTION 10 0.1250
48 ACUTE MYELOID LEUKAEMIA RECURRENT 267 0.1242
49 ACQUIRED MACROGLOSSIA 11 0.1236
50 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 30 0.1224
51 LACTOBACILLUS INFECTION 20 0.1220
52 BLOOD STEM CELL TRANSPLANT FAILURE 26 0.1209
53 HUMAN POLYOMAVIRUS INFECTION 64 0.1205
54 SERRATIA SEPSIS 13 0.1204
55 ADENOVIRAL HEPATITIS 28 0.1191
56 OVARIAN FAILURE 63 0.1178
57 BK VIRUS INFECTION 391 0.1158
58 CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG 20 0.1156
59 ALLOGENIC STEM CELL TRANSPLANTATION 18 0.1139
60 MENINGITIS ENTEROCOCCAL 9 0.1139
61 POIKILODERMA 12 0.1111
62 CYSTITIS HAEMORRHAGIC 442 0.1095
63 LARYNGITIS FUNGAL 14 0.1085
64 GASTRITIS FUNGAL 11 0.1068
65 SPINAL INSTABILITY 27 0.1063
66 ADENOVIRUS REACTIVATION 15 0.1042
67 HEPATIC VEIN OCCLUSION 16 0.1013
68 GRAFT VERSUS HOST DISEASE IN LIVER 72 0.1006
69 ENCEPHALITIS CYTOMEGALOVIRUS 43 0.0982
70 TOOTH HYPOPLASIA 17 0.0977
71 CONGENITAL APLASIA 30 0.0965
72 TRANSPLANT FAILURE 228 0.0929
73 ORAL LICHENOID REACTION 10 0.0917
74 REFRACTORINESS TO PLATELET TRANSFUSION 10 0.0917
75 HUMAN HERPESVIRUS 6 ENCEPHALITIS 25 0.0880
76 HERPES SIMPLEX VIRAEMIA 11 0.0880
77 CYTOMEGALOVIRUS ANTIGEN POSITIVE 16 0.0874
78 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 30 0.0855
79 BK POLYOMAVIRUS TEST POSITIVE 8 0.0833
80 MENINGITIS TUBERCULOUS 46 0.0823
81 GRAFT VERSUS HOST DISEASE IN EYE 19 0.0823
82 TOXIC ERYTHEMA OF CHEMOTHERAPY 21 0.0811
83 HUMAN HERPESVIRUS 6 INFECTION 149 0.0788
84 GRAFT VERSUS HOST DISEASE IN LUNG 37 0.0774
85 BLOOD LUTEINISING HORMONE INCREASED 19 0.0772
86 GRAFT VERSUS HOST DISEASE IN INTESTINE 10 0.0769
87 ADENOVIRUS INFECTION 222 0.0765
88 EPSTEIN-BARR VIRAEMIA 83 0.0748
89 CEREBRAL TOXOPLASMOSIS 69 0.0739
90 OBLITERATIVE BRONCHIOLITIS 95 0.0724
91 CYTOMEGALOVIRUS VIRAEMIA 319 0.0716
92 PARASPINAL ABSCESS 11 0.0710
93 TOXOPLASMOSIS 73 0.0676
94 ENTEROBACTER SEPSIS 25 0.0676
95 POST TRANSPLANT DISTAL LIMB SYNDROME 13 0.0640
96 ADENOMATOUS POLYPOSIS COLI 9 0.0638
97 ACANTHAMOEBA INFECTION 12 0.0638
98 GASTROENTERITIS ADENOVIRUS 10 0.0637
99 RHINOCEREBRAL MUCORMYCOSIS 22 0.0634
100 COLITIS EROSIVE 10 0.0629
101 ENTEROBACTER BACTERAEMIA 19 0.0627
102 ADENOVIRAL HAEMORRHAGIC CYSTITIS 13 0.0625
103 POLYOMAVIRUS VIRAEMIA 66 0.0621
104 ALTERNARIA INFECTION 23 0.0618
105 PNEUMONIA CYTOMEGALOVIRAL 120 0.0617
106 HEPATOSPLENIC CANDIDIASIS 9 0.0612
107 DISSEMINATED MUCORMYCOSIS 24 0.0609
108 PNEUMONIA ADENOVIRAL 12 0.0606
109 MESANGIOPROLIFERATIVE GLOMERULONEPHRITIS 9 0.0588
110 JC VIRUS INFECTION 93 0.0581
111 NODULAR MELANOMA 10 0.0578
112 PREMATURE MENOPAUSE 53 0.0574
113 TRANSPLANTATION COMPLICATION 24 0.0571
114 RETICULOCYTOSIS 12 0.0566
115 SWEAT GLAND TUMOUR 13 0.0553
116 HYPOURICAEMIA 16 0.0552
117 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 272 0.0534
118 CYTOMEGALOVIRUS INFECTION 881 0.0530
119 ANTI-PLATELET ANTIBODY POSITIVE 9 0.0520
120 PARENTERAL NUTRITION 12 0.0519
121 EPSTEIN-BARR VIRUS INFECTION 320 0.0512
122 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 20 0.0512
123 ENTEROCOCCAL BACTERAEMIA 53 0.0500
124 GRAFT COMPLICATION 29 0.0494
125 APLASTIC ANAEMIA 256 0.0490
126 PULMONARY VENO-OCCLUSIVE DISEASE 34 0.0486
127 ACUTE MYELOID LEUKAEMIA REFRACTORY 8 0.0465
128 CYTOMEGALOVIRUS TEST POSITIVE 82 0.0460
129 DEVICE RELATED BACTERAEMIA 14 0.0452
130 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 78 0.0441
131 LEUKAEMIA RECURRENT 74 0.0437
132 INFECTION REACTIVATION 50 0.0437
133 VASCULAR MALFORMATION 9 0.0429
134 MUCOSAL INFLAMMATION 1121 0.0428
135 MENINGOENCEPHALITIS HERPETIC 19 0.0424
136 CENTRAL HYPOTHYROIDISM 14 0.0423
137 KLEBSIELLA BACTERAEMIA 39 0.0411
138 SYSTEMIC MYCOSIS 47 0.0402
139 HERPES SIMPLEX TEST POSITIVE 8 0.0402
140 CELLULITIS STAPHYLOCOCCAL 26 0.0399
141 STENOTROPHOMONAS INFECTION 54 0.0398
142 ENTEROCOLITIS VIRAL 12 0.0395
143 CYTOMEGALOVIRUS CHORIORETINITIS 77 0.0394
144 TRANSPLANT DYSFUNCTION 70 0.0392
145 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 101 0.0391
146 THROMBOTIC MICROANGIOPATHY 378 0.0387
147 CHLOROMA 16 0.0379
148 RESPIRATORY TRACT INFECTION FUNGAL 20 0.0379
149 RENAL TUBULAR INJURY 46 0.0379
150 ENCEPHALITIS VIRAL 46 0.0378
151 NEUTROPENIC INFECTION 36 0.0376
152 CYTOMEGALOVIRUS GASTROENTERITIS 8 0.0370
153 MUCORMYCOSIS 96 0.0369
154 FOCAL NODULAR HYPERPLASIA 19 0.0365
155 KLEBSIELLA SEPSIS 40 0.0355
156 COOMBS DIRECT TEST POSITIVE 11 0.0353
157 ENAMEL ANOMALY 10 0.0350
158 KLEBSIELLA URINARY TRACT INFECTION 9 0.0340
159 CANDIDA SEPSIS 30 0.0334
160 LOWER RESPIRATORY TRACT INFECTION FUNGAL 13 0.0334
161 VARICELLA ZOSTER VIRUS INFECTION 69 0.0333
162 RESTRICTIVE CARDIOMYOPATHY 10 0.0330
163 PRIMARY ADRENAL INSUFFICIENCY 10 0.0328
164 GROWTH HORMONE DEFICIENCY 13 0.0327
165 DEMYELINATING POLYNEUROPATHY 33 0.0321
166 GASTROINTESTINAL MUCOSAL DISORDER 21 0.0321
167 CEREBRAL FUNGAL INFECTION 9 0.0318
168 CYTOMEGALOVIRUS GASTRITIS 8 0.0316
169 CYTOMEGALOVIRUS ENTERITIS 11 0.0309
170 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 293 0.0307
171 BACTERIAL SEPSIS 96 0.0294
172 VENOUS HAEMORRHAGE 9 0.0290
173 HERPES SIMPLEX REACTIVATION 11 0.0289
174 POLYSEROSITIS 12 0.0282
175 METAPNEUMOVIRUS INFECTION 22 0.0281
176 MYCOBACTERIUM HAEMOPHILUM INFECTION 8 0.0280
177 BRONCHOPULMONARY ASPERGILLOSIS 217 0.0280
178 PSEUDOMONAL SEPSIS 49 0.0280
179 HYPERFERRITINAEMIA 12 0.0278
180 RED BLOOD CELL SCHISTOCYTES PRESENT 9 0.0278
181 AUTOIMMUNE HAEMOLYTIC ANAEMIA 95 0.0277
182 ANGIODYSPLASIA 10 0.0275
183 BLADDER HYPERTROPHY 12 0.0271
184 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 25 0.0270
185 ACIDOSIS HYPERCHLORAEMIC 16 0.0269
186 DYSBIOSIS 22 0.0268
187 BLADDER TAMPONADE 8 0.0264
188 EVANS SYNDROME 13 0.0264
189 VIRAL DIARRHOEA 9 0.0262
190 CORNEAL LESION 8 0.0260
191 SYSTEMIC CANDIDA 65 0.0259
192 FUSARIUM INFECTION 18 0.0257
193 SINUSITIS FUNGAL 20 0.0249
194 GLOMERULONEPHRITIS MINIMAL LESION 18 0.0248
195 MICROANGIOPATHY 23 0.0245
196 PNEUMONIA KLEBSIELLA 45 0.0245
197 STEM CELL TRANSPLANT 61 0.0244
198 HERPES SIMPLEX 157 0.0241
199 CHRONIC MYELOID LEUKAEMIA RECURRENT 13 0.0238
200 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 11 0.0236
201 ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED 8 0.0234
202 CAPILLARY LEAK SYNDROME 48 0.0232
203 ENTEROCOCCAL INFECTION 112 0.0232
204 BACTERAEMIA 275 0.0231
205 SERRATIA INFECTION 17 0.0228
206 COMPLICATIONS OF TRANSPLANT SURGERY 11 0.0218
207 DIFFUSE ALVEOLAR DAMAGE 25 0.0217
208 SPLENIC VEIN THROMBOSIS 11 0.0217
209 FUNGAL SEPSIS 18 0.0217
210 FAT NECROSIS 13 0.0214
211 CEREBRAL ARTERY THROMBOSIS 11 0.0214
212 GROWTH RETARDATION 63 0.0214
213 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 18 0.0214
214 PNEUMONIA FUNGAL 84 0.0213
215 SCEDOSPORIUM INFECTION 15 0.0212
216 STREPTOCOCCAL BACTERAEMIA 23 0.0211
217 ROTAVIRUS INFECTION 12 0.0208
218 CRANIAL NERVE DISORDER 14 0.0200
219 KLEBSIELLA INFECTION 101 0.0200
220 PARVOVIRUS INFECTION 8 0.0198
221 CEREBRAL ASPERGILLOSIS 12 0.0195
222 RED BLOOD CELL TRANSFUSION 8 0.0195
223 LICHENIFICATION 8 0.0195
224 BONE MARROW TOXICITY 23 0.0194
225 STEROID DEPENDENCE 17 0.0194
226 NEUTROPENIC COLITIS 40 0.0193
227 ANAEMIA HAEMOLYTIC AUTOIMMUNE 16 0.0193
228 MYCOPLASMA INFECTION 15 0.0192
229 SMOOTH MUSCLE CELL NEOPLASM 8 0.0191
230 FUNGAEMIA 30 0.0190
231 PERICARDITIS CONSTRICTIVE 8 0.0190
232 HYPERPLASIA 17 0.0189
233 MYELITIS 29 0.0187
234 HAPTOGLOBIN DECREASED 15 0.0186
235 RETICULOCYTE COUNT INCREASED 15 0.0185
236 APLASIA 36 0.0184
237 PANCREATIC ATROPHY 8 0.0183
238 ENCEPHALITIS HERPES 9 0.0182
239 SEROSITIS 10 0.0181
240 VIRAEMIA 25 0.0180
241 SEPTIC EMBOLUS 15 0.0180
242 PARVOVIRUS B19 INFECTION 16 0.0179
243 GLOMERULONEPHRITIS MEMBRANOUS 21 0.0179
244 ESCHERICHIA BACTERAEMIA 42 0.0178
245 PARAINFLUENZAE VIRUS INFECTION 27 0.0177
246 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 146 0.0177
247 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 8 0.0174
248 HYPOTHALAMO-PITUITARY DISORDER 25 0.0172
249 STAPHYLOCOCCAL SEPSIS 82 0.0166
250 MINIMAL RESIDUAL DISEASE 8 0.0166
251 BLOOD BILIRUBIN UNCONJUGATED INCREASED 12 0.0165
252 NEOPLASM RECURRENCE 56 0.0165
253 SUPERINFECTION BACTERIAL 13 0.0164
254 PULMONARY HAEMORRHAGE 127 0.0162
255 RHINOVIRUS INFECTION 63 0.0162
256 ASPERGILLOSIS 21 0.0161
257 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 23 0.0160
258 ESCHERICHIA TEST POSITIVE 19 0.0159
259 ASPERGILLUS INFECTION 103 0.0157
260 EXTREMITY CONTRACTURE 10 0.0156
261 ACUTE PROMYELOCYTIC LEUKAEMIA 16 0.0156
262 PLATELET TRANSFUSION 20 0.0155
263 GASTROINTESTINAL TOXICITY 74 0.0154
264 CRYPTOSPORIDIOSIS INFECTION 8 0.0152
265 PNEUMOCOCCAL SEPSIS 10 0.0152
266 ALVEOLAR PROTEINOSIS 9 0.0152
267 GASTRIC MUCOSAL LESION 11 0.0151
268 CORYNEBACTERIUM INFECTION 8 0.0150
269 CUSHINGOID 48 0.0149
270 ENTEROCOCCAL SEPSIS 12 0.0148
271 HUMAN HERPESVIRUS 8 INFECTION 9 0.0148
272 BLOOD BILIRUBIN DECREASED 9 0.0146
273 HEPATOBILIARY DISEASE 9 0.0144
274 ADRENAL HAEMORRHAGE 8 0.0143
275 BACILLUS INFECTION 9 0.0142
276 STAPHYLOCOCCAL BACTERAEMIA 61 0.0140
277 DIARRHOEA INFECTIOUS 11 0.0140
278 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 11 0.0140
279 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 143 0.0139
280 BLOOD IMMUNOGLOBULIN A DECREASED 9 0.0138
281 KLEBSIELLA TEST POSITIVE 9 0.0138
282 PULMONARY ALVEOLAR HAEMORRHAGE 77 0.0137
283 HILAR LYMPHADENOPATHY 12 0.0136
284 STREPTOCOCCAL SEPSIS 16 0.0135
285 CYTOMEGALOVIRUS COLITIS 31 0.0135
286 FEBRILE NEUTROPENIA 886 0.0133
287 ACUTE MYELOID LEUKAEMIA 206 0.0132
288 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 35 0.0131
289 SURGICAL PROCEDURE REPEATED 9 0.0131
290 CYTOMEGALOVIRUS ENTEROCOLITIS 10 0.0130
291 HYPOGAMMAGLOBULINAEMIA 85 0.0129
292 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 97 0.0129
293 MULTIPLE ORGAN DYSFUNCTION SYNDROME 366 0.0129
294 URINARY TRACT INFECTION BACTERIAL 32 0.0126
295 BRAIN ABSCESS 32 0.0126
296 PNEUMONIA INFLUENZAL 15 0.0126
297 NOCARDIOSIS 32 0.0125
298 ENDOCRINE DISORDER 16 0.0125
299 TRANSPLANT REJECTION 100 0.0125
300 HERPES ZOSTER DISSEMINATED 10 0.0125
301 CLOSTRIDIUM DIFFICILE COLITIS 132 0.0124
302 BONE MARROW DEPRESSION 12 0.0123
303 IMMUNE THROMBOCYTOPENIA 56 0.0122
304 BONE MARROW TRANSPLANT 23 0.0121
305 GASTROENTERITIS NOROVIRUS 16 0.0120
306 CAMPYLOBACTER INFECTION 10 0.0120
307 SKIN TOXICITY 68 0.0120
308 HEPATIC NECROSIS 45 0.0119
309 MUCOSAL ULCERATION 12 0.0119
310 DISSEMINATED CRYPTOCOCCOSIS 9 0.0119
311 ACINETOBACTER INFECTION 13 0.0119
312 HEPATORENAL SYNDROME 20 0.0118
313 GLYCOSURIA 16 0.0118
314 PSEUDOMONAL BACTERAEMIA 10 0.0117
315 VANISHING BILE DUCT SYNDROME 13 0.0117
316 BONE MARROW FAILURE 235 0.0116
317 SOFT TISSUE INFECTION 21 0.0115
318 GUILLAIN-BARRE SYNDROME 55 0.0114
319 PELVIC FLUID COLLECTION 8 0.0113
320 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 14 0.0113
321 ENTEROBACTER INFECTION 19 0.0113
322 LYMPHOPROLIFERATIVE DISORDER 33 0.0112
323 PNEUMATOSIS INTESTINALIS 32 0.0112
324 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 9 0.0111
325 GRAFT LOSS 8 0.0110
326 ESCHERICHIA SEPSIS 32 0.0110
327 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 67 0.0110
328 LYMPH NODE TUBERCULOSIS 8 0.0108
329 LUNG CONSOLIDATION 30 0.0107
330 PNEUMONIA STAPHYLOCOCCAL 21 0.0106
331 PULMONARY TOXICITY 74 0.0105
332 PSEUDOMONAS INFECTION 89 0.0104
333 EPIDIDYMITIS 12 0.0103
334 MENINGITIS CRYPTOCOCCAL 18 0.0103
335 ADENOCARCINOMA PANCREAS 13 0.0101
336 HEPATITIS B REACTIVATION 32 0.0101
337 MUCOSAL DISORDER 10 0.0101
338 AUTOIMMUNE THYROIDITIS 38 0.0100
339 BLOOD CULTURE POSITIVE 30 0.0100
340 HYPOPROTEINAEMIA 19 0.0100
341 HEART TRANSPLANT 9 0.0099
342 SECONDARY ADRENOCORTICAL INSUFFICIENCY 15 0.0099
343 ACUTE RESPIRATORY DISTRESS SYNDROME 172 0.0097
344 WHITE MATTER LESION 12 0.0095
345 ACTINOMYCOSIS 9 0.0094
346 HAEMATOTOXICITY 89 0.0094
347 MYELODYSPLASTIC SYNDROME 135 0.0093
348 DRUG CLEARANCE DECREASED 12 0.0092
349 NEPHROPATHY TOXIC 103 0.0092
350 SPINAL CORD DISORDER 15 0.0091
351 STAPHYLOCOCCUS TEST POSITIVE 19 0.0090
352 NOROVIRUS INFECTION 13 0.0090
353 APLASIA PURE RED CELL 31 0.0090
354 VITILIGO 21 0.0089
355 PNEUMONIA VIRAL 28 0.0088
356 HISTIOCYTOSIS HAEMATOPHAGIC 26 0.0087
357 PORTAL HYPERTENSION 27 0.0087
358 PNEUMOCYSTIS JIROVECII PNEUMONIA 87 0.0087
359 MYELITIS TRANSVERSE 12 0.0085
360 ACTINIC KERATOSIS 22 0.0085
361 PNEUMOCYSTIS JIROVECII INFECTION 10 0.0084
362 LEUKOENCEPHALOPATHY 31 0.0083
363 ORGANISING PNEUMONIA 41 0.0083
364 ESCHERICHIA INFECTION 68 0.0083
365 HEPATOMEGALY 81 0.0082
366 PANCYTOPENIA 459 0.0082
367 BACTERIAL INFECTION 153 0.0082
368 HYPERBILIRUBINAEMIA 84 0.0081
369 BLOOD IMMUNOGLOBULIN M DECREASED 8 0.0080
370 PNEUMONIA BACTERIAL 73 0.0079
371 CORTISOL DECREASED 9 0.0079
372 GASTROINTESTINAL BACTERIAL INFECTION 9 0.0079
373 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 30 0.0078
374 FANCONI SYNDROME 11 0.0078
375 CARDIOTOXICITY 69 0.0077
376 LIP ULCERATION 9 0.0077
377 PULMONARY FUNCTION TEST ABNORMAL 12 0.0077
378 ENCEPHALITIS 53 0.0077
379 RECURRENT CANCER 31 0.0076
380 CYTOPENIA 93 0.0076
381 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 12 0.0075
382 HAEMORRHAGE URINARY TRACT 19 0.0075
383 MULTIPLE-DRUG RESISTANCE 23 0.0074
384 PHARYNGEAL INFLAMMATION 9 0.0074
385 NEUROLOGICAL DECOMPENSATION 17 0.0073
386 MULTI-ORGAN FAILURE 125 0.0072
387 URINARY TRACT OBSTRUCTION 17 0.0072
388 LIP HAEMORRHAGE 9 0.0071
389 SEPTIC SHOCK 306 0.0070
390 CANDIDA INFECTION 118 0.0070
391 PRODUCT USE IN UNAPPROVED INDICATION 1727 0.0070
392 CARDIAC TAMPONADE 33 0.0069
393 HERPES OPHTHALMIC 9 0.0068
394 PARAPARESIS 12 0.0067
395 ACUTE LYMPHOCYTIC LEUKAEMIA 19 0.0067
396 BRAIN HERNIATION 20 0.0067
397 RESPIRATORY FAILURE 487 0.0067
398 LONG QT SYNDROME 16 0.0067
399 DISSEMINATED TUBERCULOSIS 17 0.0066
400 VENOUS THROMBOSIS 26 0.0066
401 GENE MUTATION 13 0.0066
402 LICHENOID KERATOSIS 15 0.0066
403 NEUROTOXICITY 114 0.0065
404 SECOND PRIMARY MALIGNANCY 54 0.0065
405 ASCITES 189 0.0064
406 FEBRILE BONE MARROW APLASIA 27 0.0063
407 HAEMATOLOGICAL MALIGNANCY 18 0.0063
408 BACTERIAL TEST POSITIVE 14 0.0063
409 LYMPHADENOPATHY MEDIASTINAL 12 0.0063
410 BLOOD BILIRUBIN ABNORMAL 8 0.0062
411 HEPATOSPLENOMEGALY 16 0.0062
412 PERICARDIAL EFFUSION 144 0.0062
413 VASCULAR DEVICE INFECTION 28 0.0062
414 HAEMATOLOGICAL INFECTION 15 0.0061
415 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 16 0.0061
416 DEVICE RELATED INFECTION 94 0.0061
417 PNEUMONIA PNEUMOCOCCAL 9 0.0061
418 CERVICAL DYSPLASIA 13 0.0059
419 STAPHYLOCOCCAL INFECTION 194 0.0059
420 CENTRAL NERVOUS SYSTEM LYMPHOMA 8 0.0058
421 MYCOBACTERIAL INFECTION 10 0.0058
422 NEOPLASM SKIN 9 0.0058
423 PERIPHERAL MOTOR NEUROPATHY 8 0.0057
424 LUNG OPACITY 15 0.0057
425 TRAUMATIC LUNG INJURY 11 0.0057
426 END STAGE RENAL DISEASE 103 0.0056
427 DRUG RESISTANCE 145 0.0056
428 MYELOFIBROSIS 17 0.0056
429 GASTROINTESTINAL INJURY 15 0.0056
430 ENTEROCOLITIS 32 0.0055
431 SUBDURAL HAEMORRHAGE 15 0.0055
432 TRANSFUSION 57 0.0054
433 PNEUMOCYSTIS JIROVECI PNEUMONIA 12 0.0054
434 HAEMOLYSIS 41 0.0053
435 MYELOPATHY 10 0.0053
436 BRONCHIECTASIS 35 0.0052
437 THROMBOCYTOPENIA 577 0.0052
438 POLYMYOSITIS 9 0.0051
439 PULMONARY HYPERTENSION 105 0.0050
440 IMMUNE THROMBOCYTOPENIC PURPURA 14 0.0049
441 PORTAL VEIN THROMBOSIS 16 0.0049
442 RESPIRATORY ALKALOSIS 8 0.0049
443 RIGHT VENTRICULAR FAILURE 34 0.0048
444 DIFFUSE ALOPECIA 9 0.0048
445 SEPSIS 540 0.0048
446 THROMBOTIC THROMBOCYTOPENIC PURPURA 17 0.0048
447 CYTOLYTIC HEPATITIS 16 0.0048
448 RESPIRATORY DISTRESS 132 0.0048
449 BLOOD BILIRUBIN INCREASED 129 0.0048
450 LUNG ABSCESS 10 0.0048
451 CHRONIC MYELOID LEUKAEMIA 22 0.0048
452 SALMONELLOSIS 8 0.0047
453 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 11 0.0047
454 HERPES VIRUS INFECTION 27 0.0047
455 SHOCK HAEMORRHAGIC 38 0.0047
456 PULMONARY INFARCTION 11 0.0046
457 HEPATIC FAILURE 140 0.0046
458 LUNG INFECTION 72 0.0046
459 SKIN HYPERTROPHY 13 0.0046
460 HEPATOTOXICITY 103 0.0046
461 RENAL TUBULAR DISORDER 13 0.0046
462 BRAIN NEOPLASM 42 0.0046
463 FIBROSIS 14 0.0045
464 BRONCHIOLITIS 16 0.0045
465 NEPHROTIC SYNDROME 31 0.0045
466 CHRONIC LYMPHOCYTIC LEUKAEMIA 21 0.0044
467 LIVER TRANSPLANT 16 0.0044
468 FUNGAL INFECTION 146 0.0044
469 HYPOALBUMINAEMIA 34 0.0044
470 RESPIRATORY SYNCYTIAL VIRUS INFECTION 38 0.0044
471 GASTROINTESTINAL INFECTION 39 0.0043
472 OSTEOPENIA 66 0.0043
473 DISSEMINATED INTRAVASCULAR COAGULATION 61 0.0043
474 CARDIAC DYSFUNCTION 16 0.0043
475 ORGAN FAILURE 17 0.0042
476 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 21 0.0042
477 ARTHRITIS BACTERIAL 17 0.0041
478 GASTROINTESTINAL NECROSIS 12 0.0041
479 JUVENILE IDIOPATHIC ARTHRITIS 10 0.0041
480 CLOSTRIDIUM TEST POSITIVE 9 0.0041
481 HAEMORRHAGE INTRACRANIAL 61 0.0041
482 LUNG INFILTRATION 36 0.0041
483 PARESIS 9 0.0040
484 HYPERAMMONAEMIA 20 0.0040
485 COMPUTERISED TOMOGRAM ABNORMAL 9 0.0040
486 GASTROINTESTINAL INFLAMMATION 31 0.0040
487 NECROSIS 22 0.0039
488 HEPATIC CYTOLYSIS 50 0.0039
489 RASH MACULO-PAPULAR 87 0.0039
490 THERAPEUTIC AGENT TOXICITY 13 0.0039
491 PULMONARY ARTERIAL HYPERTENSION 56 0.0039
492 INFECTION 556 0.0038
493 LIVEDO RETICULARIS 8 0.0038
494 STOMATITIS 230 0.0038
495 VARICELLA 9 0.0038
496 ATRIAL FLUTTER 30 0.0038
497 PULMONARY TUBERCULOSIS 16 0.0037
498 CANDIDIASIS 15 0.0037
499 ENDOCARDITIS 19 0.0037
500 HAEMODYNAMIC INSTABILITY 28 0.0037
501 INTRACRANIAL PRESSURE INCREASED 20 0.0036
502 COAGULOPATHY 59 0.0035
503 BASAL CELL CARCINOMA 54 0.0035
504 CATHETER SITE INFECTION 13 0.0034
505 RESPIRATORY TRACT INFECTION VIRAL 8 0.0034
506 THROMBOPHLEBITIS 12 0.0034
507 PATHOGEN RESISTANCE 31 0.0034
508 METASTASIS 24 0.0034
509 HYPOVOLAEMIC SHOCK 16 0.0033
510 CHOLESTASIS 64 0.0033
511 LUNG ADENOCARCINOMA 10 0.0033
512 LYMPHOPENIA 47 0.0033
513 DIABETES INSIPIDUS 8 0.0033
514 CACHEXIA 17 0.0033
515 BLOOD LACTATE DEHYDROGENASE INCREASED 52 0.0033
516 NEUTROPENIA 442 0.0032
517 HAEMOLYTIC ANAEMIA 29 0.0032
518 INFLAMMATORY MARKER INCREASED 16 0.0032
519 PNEUMOTHORAX 51 0.0032
520 ATELECTASIS 31 0.0032
521 NEUTROPHIL COUNT ABNORMAL 9 0.0032
522 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 174 0.0032
523 DRUG TOXICITY 43 0.0032
524 SPINAL STENOSIS 13 0.0031
525 THERAPY PARTIAL RESPONDER 49 0.0031
526 ORAL DISORDER 23 0.0031
527 CONGESTIVE CARDIOMYOPATHY 13 0.0031
528 PYELONEPHRITIS 27 0.0031
529 FAILURE TO THRIVE 16 0.0031
530 CARDIOPULMONARY FAILURE 12 0.0031
531 ESCHERICHIA URINARY TRACT INFECTION 13 0.0031
532 BONE LESION 11 0.0030
533 URINE ANALYSIS ABNORMAL 9 0.0030
534 BRAIN OEDEMA 38 0.0030
535 SPLENOMEGALY 35 0.0030
536 TOXIC SKIN ERUPTION 30 0.0030
537 HAEMATURIA 102 0.0030
538 ANAL ABSCESS 16 0.0030
539 EMBOLISM VENOUS 9 0.0030
540 TOXIC ENCEPHALOPATHY 15 0.0030
541 CLOSTRIDIAL INFECTION 10 0.0030
542 STATUS EPILEPTICUS 33 0.0029
543 ACUTE RESPIRATORY FAILURE 56 0.0029
544 GENERALISED OEDEMA 36 0.0029
545 LEUKAEMIA 27 0.0029
546 MYELOSUPPRESSION 103 0.0029
547 ENCEPHALOPATHY 70 0.0028
548 NECROTISING FASCIITIS 10 0.0028
549 ENTERITIS 18 0.0028
550 GRANULOCYTOPENIA 16 0.0028
551 NEUROLOGICAL SYMPTOM 16 0.0028
552 DERMATITIS BULLOUS 20 0.0028
553 SQUAMOUS CELL CARCINOMA 26 0.0028
554 HEPATITIS FULMINANT 8 0.0027
555 LEFT VENTRICULAR DYSFUNCTION 18 0.0027
556 DEMYELINATION 11 0.0027
557 MALABSORPTION 14 0.0027
558 ATYPICAL PNEUMONIA 8 0.0027
559 CLOSTRIDIUM DIFFICILE INFECTION 58 0.0027
560 PNEUMONITIS 72 0.0026
561 LYMPHADENOPATHY 93 0.0026
562 HYPERPYREXIA 11 0.0026
563 DIFFUSE LARGE B-CELL LYMPHOMA 20 0.0026
564 TOXIC EPIDERMAL NECROLYSIS 39 0.0026
565 DIARRHOEA HAEMORRHAGIC 24 0.0026
566 TRANSAMINASES INCREASED 57 0.0026
567 LOSS OF THERAPEUTIC RESPONSE 8 0.0025
568 PLEURAL EFFUSION 152 0.0025
569 STUPOR 8 0.0025
570 PARTIAL SEIZURES 13 0.0025
571 JOINT EFFUSION 17 0.0025
572 EJECTION FRACTION DECREASED 38 0.0024
573 SKIN HYPERPIGMENTATION 21 0.0024
574 DEAFNESS NEUROSENSORY 8 0.0024
575 MYOPATHY 21 0.0024
576 ORAL CANDIDIASIS 32 0.0024
577 OTITIS MEDIA 8 0.0024
578 ABDOMINAL TENDERNESS 12 0.0024
579 RESPIRATORY DISORDER 72 0.0024
580 OFF LABEL USE 2098 0.0024
581 PYREXIA 827 0.0024
582 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 70 0.0024
583 HYPOXIA 84 0.0024
584 HYPERTHERMIA 18 0.0024
585 HEPATIC PAIN 10 0.0023
586 PROCTALGIA 15 0.0023
587 LEFT VENTRICULAR FAILURE 8 0.0023
588 INTENTIONAL PRODUCT USE ISSUE 202 0.0023
589 CARDIOMYOPATHY 34 0.0023
590 SERUM FERRITIN INCREASED 12 0.0023
591 DISEASE RECURRENCE 108 0.0023
592 CEREBRAL ATROPHY 9 0.0023
593 DISEASE PROGRESSION 267 0.0023
594 HEPATIC ENCEPHALOPATHY 21 0.0022
595 MENINGITIS 15 0.0022
596 MALNUTRITION 25 0.0022
597 SUSPECTED OFF LABEL USE 10 0.0022
598 CARDIOMEGALY 27 0.0022
599 ODYNOPHAGIA 13 0.0022
600 POLYNEUROPATHY 26 0.0022
601 GAMMA-GLUTAMYLTRANSFERASE INCREASED 48 0.0022
602 VIRAL INFECTION 72 0.0022
603 IMMUNOSUPPRESSION 19 0.0022
604 ADRENAL INSUFFICIENCY 26 0.0021
605 ACUTE PULMONARY OEDEMA 12 0.0021
606 TACHYPNOEA 29 0.0021
607 CHOLECYSTITIS ACUTE 12 0.0021
608 INTERSTITIAL LUNG DISEASE 102 0.0021
609 RETINAL HAEMORRHAGE 15 0.0021
610 NEUTROPENIC SEPSIS 15 0.0021
611 AGRANULOCYTOSIS 39 0.0021
612 OLIGURIA 13 0.0021
613 MENTAL STATUS CHANGES 58 0.0021
614 NYSTAGMUS 11 0.0021
615 SUBARACHNOID HAEMORRHAGE 21 0.0021
616 SKIN LESION 56 0.0020
617 TUBULOINTERSTITIAL NEPHRITIS 38 0.0020
618 HYPERTRANSAMINASAEMIA 14 0.0020
619 OESOPHAGEAL CANDIDIASIS 8 0.0020
620 LUNG DISORDER 98 0.0020
621 HEPATITIS 51 0.0020
622 HEPATITIS B 12 0.0020
623 C-REACTIVE PROTEIN INCREASED 72 0.0020
624 HEPATOCELLULAR INJURY 28 0.0020
625 ACUTE KIDNEY INJURY 302 0.0020
626 SKIN MASS 13 0.0019
627 CEREBRAL ISCHAEMIA 10 0.0019
628 HEPATIC STEATOSIS 36 0.0019
629 CHOLECYSTITIS 23 0.0019
630 PERIORBITAL OEDEMA 10 0.0019
631 OESOPHAGITIS 21 0.0019
632 PULSELESS ELECTRICAL ACTIVITY 8 0.0019
633 HAEMODIALYSIS 16 0.0019
634 RENAL IMPAIRMENT 160 0.0019
635 HEPATIC FUNCTION ABNORMAL 71 0.0019
636 HALLUCINATIONS, MIXED 8 0.0019
637 CEREBRAL HAEMORRHAGE 68 0.0019
638 LUNG NEOPLASM 8 0.0019
639 THERAPY NON-RESPONDER 84 0.0019
640 MELAENA 41 0.0019
641 HEPATITIS ACUTE 12 0.0018
642 HYDROCEPHALUS 10 0.0018
643 RENAL FAILURE 243 0.0018
644 PULMONARY OEDEMA 81 0.0018
645 ELECTROLYTE IMBALANCE 21 0.0018
646 HYPERNATRAEMIA 9 0.0018
647 CYTOKINE RELEASE SYNDROME 36 0.0018
648 BLOOD UREA INCREASED 30 0.0018
649 COVID-19 PNEUMONIA 21 0.0018
650 ASPARTATE AMINOTRANSFERASE INCREASED 94 0.0018
651 ALANINE AMINOTRANSFERASE INCREASED 108 0.0018
652 LOWER GASTROINTESTINAL HAEMORRHAGE 13 0.0018
653 ACUTE HEPATIC FAILURE 24 0.0018
654 CARDIOGENIC SHOCK 24 0.0017
655 JAUNDICE 45 0.0017
656 MOTOR DYSFUNCTION 17 0.0017
657 CYSTITIS 53 0.0017
658 TORSADE DE POINTES 13 0.0017
659 RED BLOOD CELL SEDIMENTATION RATE INCREASED 18 0.0016
660 HYPOPHOSPHATAEMIA 12 0.0016
661 SUBDURAL HAEMATOMA 23 0.0016
662 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 37 0.0016
663 AUTOIMMUNE HEPATITIS 11 0.0016
664 PROTEINURIA 30 0.0016
665 HYPERTENSION 333 0.0016
666 ACIDOSIS 12 0.0016
667 PNEUMONIA 505 0.0016
668 SKIN NECROSIS 8 0.0015
669 ILEUS 19 0.0015
670 VISUAL FIELD DEFECT 11 0.0015
671 GASTROINTESTINAL HAEMORRHAGE 127 0.0015
672 LIVER FUNCTION TEST ABNORMAL 44 0.0015
673 CARDIAC FAILURE ACUTE 10 0.0015
674 MOUTH HAEMORRHAGE 11 0.0015
675 HAEMATEMESIS 38 0.0015
676 SEIZURE 173 0.0015
677 HYPERCALCAEMIA 18 0.0015
678 STREPTOCOCCAL INFECTION 8 0.0014
679 RENAL TUBULAR NECROSIS 14 0.0014
680 FRACTURE 27 0.0014
681 BLOOD ALKALINE PHOSPHATASE INCREASED 35 0.0014
682 MYOCARDITIS 16 0.0014
683 GENERALISED TONIC-CLONIC SEIZURE 23 0.0014
684 DRUG LEVEL INCREASED 23 0.0014
685 ALTERED STATE OF CONSCIOUSNESS 30 0.0014
686 ABSCESS 22 0.0014
687 RALES 8 0.0014
688 FLUID OVERLOAD 20 0.0014
689 HYPERTRIGLYCERIDAEMIA 8 0.0014
690 HYPOMAGNESAEMIA 19 0.0014
691 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 8 0.0013
692 ATAXIA 16 0.0013
693 HYPERCHOLESTEROLAEMIA 13 0.0013
694 MYOCLONUS 16 0.0013
695 SKIN INFECTION 15 0.0013
696 MOUTH ULCERATION 28 0.0013
697 OSTEONECROSIS 43 0.0013
698 DIPLOPIA 34 0.0013
699 GRAND MAL CONVULSION 12 0.0013
700 HYPOPHAGIA 33 0.0013
701 FACIAL PARALYSIS 11 0.0013
702 APNOEA 10 0.0013
703 HYPOTHYROIDISM 41 0.0013
704 ORAL HERPES 25 0.0013
705 ANURIA 11 0.0013
706 NEOPLASM PROGRESSION 44 0.0013
707 BLOOD ALBUMIN DECREASED 10 0.0013
708 VENTRICULAR FIBRILLATION 14 0.0013
709 HERPES ZOSTER 72 0.0013
710 PULMONARY FIBROSIS 24 0.0012
711 TUMOUR LYSIS SYNDROME 11 0.0012
712 EPILEPSY 38 0.0012
713 DERMATITIS 26 0.0012
714 TOXICITY TO VARIOUS AGENTS 209 0.0012
715 ANAEMIA 235 0.0012
716 DYSGRAPHIA 8 0.0012
717 LIVER FUNCTION TEST INCREASED 26 0.0012
718 CARDIAC FAILURE 97 0.0012
719 CONVULSION 68 0.0012
720 UPPER GASTROINTESTINAL HAEMORRHAGE 20 0.0012
721 APPENDICITIS 11 0.0012
722 SHOCK 27 0.0012
723 LIVER DISORDER 52 0.0012
724 HYPERLIPIDAEMIA 14 0.0012
725 OBSTRUCTIVE AIRWAYS DISORDER 13 0.0012
726 HEPATITIS C 14 0.0012
727 CARDIO-RESPIRATORY ARREST 48 0.0011
728 GLOMERULAR FILTRATION RATE DECREASED 14 0.0011
729 PLATELET COUNT DECREASED 121 0.0011
730 DUODENAL ULCER 8 0.0011
731 PERICARDITIS 19 0.0011
732 GASTRIC HAEMORRHAGE 13 0.0011
733 NEUTROPHIL COUNT DECREASED 46 0.0011
734 AUTOIMMUNE DISORDER 11 0.0011
735 CIRCULATORY COLLAPSE 19 0.0011
736 DRUG-INDUCED LIVER INJURY 35 0.0011
737 ASPIRATION 12 0.0011
738 ANOREXIA 14 0.0011
739 COLITIS 41 0.0011
740 IMMUNODEFICIENCY 16 0.0011
741 RENAL DISORDER 50 0.0011
742 ISCHAEMIC STROKE 19 0.0011
743 REBOUND EFFECT 12 0.0011
744 RENAL FAILURE ACUTE 45 0.0011
745 HYPOCALCAEMIA 20 0.0011
746 RESPIRATORY TRACT INFECTION 27 0.0010
747 STEVENS-JOHNSON SYNDROME 23 0.0010
748 HEPATIC ENZYME INCREASED 70 0.0010
749 TREATMENT FAILURE 85 0.0010
750 OEDEMA 55 0.0010
751 PULMONARY MASS 15 0.0010
752 LEUKOCYTOSIS 18 0.0010
753 BLOOD COUNT ABNORMAL 15 0.0010
754 HYPERGLYCAEMIA 36 0.0010
755 DIALYSIS 14 0.0010
756 LIVER INJURY 24 0.0010
757 EPISTAXIS 73 0.0010
758 HAEMORRHAGE 102 0.0010
759 BLOOD CREATININE INCREASED 63 0.0010
760 RASH ERYTHEMATOUS 46 0.0010
761 GASTROENTERITIS 14 0.0010
762 POST PROCEDURAL HAEMORRHAGE 11 0.0009
763 METABOLIC ACIDOSIS 30 0.0009
764 HAEMOPTYSIS 26 0.0009
765 DYSURIA 34 0.0009
766 DRUG INTOLERANCE 88 0.0009
767 BLINDNESS 37 0.0009
768 LYMPHOMA 14 0.0009
769 IMPAIRED QUALITY OF LIFE 13 0.0009
770 MENINGIOMA 14 0.0009
771 INFLAMMATION 46 0.0009
772 UPPER RESPIRATORY TRACT INFECTION 41 0.0009
773 DRUG LEVEL DECREASED 9 0.0009
774 HIDRADENITIS 8 0.0009
775 NERVOUS SYSTEM DISORDER 27 0.0009
776 RECTAL HAEMORRHAGE 37 0.0009
777 EYELID OEDEMA 10 0.0009
778 THERAPEUTIC RESPONSE DECREASED 52 0.0009
779 AMENORRHOEA 15 0.0009
780 CELLULITIS 43 0.0009
781 HYPOKALAEMIA 39 0.0008
782 GASTROINTESTINAL DISORDER 74 0.0008
783 DRUG INEFFECTIVE 1088 0.0008
784 NO THERAPEUTIC RESPONSE 10 0.0008
785 SMALL INTESTINAL OBSTRUCTION 10 0.0008
786 CARDIAC ARREST 67 0.0008
787 TOOTH DISORDER 18 0.0008
788 DRUG INTERACTION 128 0.0008
789 BLADDER DISORDER 8 0.0008
790 EYELID PTOSIS 8 0.0008
791 DIARRHOEA 503 0.0008
792 INTERVERTEBRAL DISC PROTRUSION 17 0.0008
793 PRODUCT USE ISSUE 146 0.0008
794 FACE OEDEMA 13 0.0008
795 FOLLICULITIS 8 0.0008
796 MALIGNANT NEOPLASM PROGRESSION 78 0.0008
797 IMMUNE SYSTEM DISORDER 10 0.0008
798 CONJUNCTIVITIS 14 0.0008
799 QUALITY OF LIFE DECREASED 10 0.0007
800 LEUKOPENIA 37 0.0007
801 BIPOLAR DISORDER 8 0.0007
802 CENTRAL NERVOUS SYSTEM LESION 10 0.0007
803 ABDOMINAL PAIN 166 0.0007
804 DEPRESSED LEVEL OF CONSCIOUSNESS 28 0.0007
805 METASTASES TO CENTRAL NERVOUS SYSTEM 9 0.0007
806 HEPATIC CIRRHOSIS 13 0.0007
807 PLATELET COUNT INCREASED 9 0.0007
808 PNEUMONIA ASPIRATION 17 0.0007
809 DEEP VEIN THROMBOSIS 44 0.0007
810 SKIN HAEMORRHAGE 10 0.0007
811 MALIGNANT MELANOMA 9 0.0007
812 APHASIA 20 0.0007
813 HAEMATOMA 17 0.0007
814 DISORIENTATION 26 0.0007
815 CEREBRAL INFARCTION 16 0.0007
816 FLUID RETENTION 33 0.0006
817 GENERAL PHYSICAL HEALTH DETERIORATION 75 0.0006
818 SINUS TACHYCARDIA 9 0.0006
819 ORAL PAIN 14 0.0006
820 CATARACT 37 0.0006
821 NEOPLASM MALIGNANT 41 0.0006
822 COMA 29 0.0006
823 OXYGEN SATURATION DECREASED 34 0.0006
824 URINARY TRACT INFECTION 103 0.0006
825 NEUROPATHY PERIPHERAL 57 0.0006
826 PRODUCT PRESCRIBING ISSUE 13 0.0006
827 FULL BLOOD COUNT DECREASED 12 0.0006
828 HYPONATRAEMIA 33 0.0006
829 ATRIAL FIBRILLATION 57 0.0006
830 DELIRIUM 20 0.0006
831 POST PROCEDURAL COMPLICATION 11 0.0006
832 WHITE BLOOD CELL COUNT DECREASED 62 0.0006
833 COVID-19 100 0.0006
834 HAEMOGLOBIN DECREASED 58 0.0006
835 HYPOTENSION 113 0.0006
836 DRY EYE 28 0.0006
837 PALLOR 15 0.0006
838 PLASMA CELL MYELOMA 21 0.0005
839 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 38 0.0005
840 GASTRITIS 14 0.0005
841 HEMIPARESIS 9 0.0005
842 TACHYCARDIA 47 0.0005
843 VOMITING 244 0.0005
844 MUSCULOSKELETAL CHEST PAIN 8 0.0005
845 HYPERKALAEMIA 18 0.0005
846 THROMBOSIS 41 0.0005
847 RESPIRATORY ARREST 14 0.0005
848 DYSPHAGIA 48 0.0005
849 UNRESPONSIVE TO STIMULI 13 0.0005
850 PRODUCTIVE COUGH 24 0.0005
851 WEIGHT INCREASED 112 0.0005
852 DEAFNESS 13 0.0005
853 OEDEMA PERIPHERAL 60 0.0005
854 PANCREATITIS ACUTE 11 0.0005
855 CONDITION AGGRAVATED 148 0.0005
856 OSTEOPOROSIS 20 0.0005
857 PERITONITIS 10 0.0005
858 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
859 URINARY RETENTION 16 0.0005
860 DYSPNOEA EXERTIONAL 18 0.0005
861 FOOT FRACTURE 9 0.0005
862 HALLUCINATION, VISUAL 10 0.0005
863 ELECTROCARDIOGRAM QT PROLONGED 17 0.0005
864 CHRONIC KIDNEY DISEASE 35 0.0005
865 EOSINOPHILIA 8 0.0005
866 GALLBLADDER DISORDER 8 0.0004
867 COUGH 124 0.0004
868 INFLUENZA 49 0.0004
869 ANAPHYLACTIC REACTION 24 0.0004
870 RHINORRHOEA 28 0.0004
871 CHILLS 50 0.0004
872 BLOOD SODIUM DECREASED 8 0.0004
873 AGITATION 31 0.0004
874 RED BLOOD CELL COUNT DECREASED 12 0.0004
875 HAEMATOCHEZIA 23 0.0004
876 FAECES DISCOLOURED 9 0.0004
877 ARTHROPATHY 23 0.0004
878 CARDIAC FAILURE CONGESTIVE 33 0.0004
879 PRODUCT ADMINISTRATION ERROR 8 0.0004
880 FEEDING DISORDER 8 0.0004
881 BODY TEMPERATURE INCREASED 8 0.0004
882 SKIN EXFOLIATION 33 0.0004
883 PULMONARY EMBOLISM 37 0.0004
884 ABDOMINAL DISTENSION 40 0.0004
885 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
886 DEATH 320 0.0004
887 NAUSEA 289 0.0004
888 WHITE BLOOD CELL COUNT INCREASED 14 0.0004
889 POLLAKIURIA 15 0.0004
890 DECREASED APPETITE 83 0.0004
891 RASH PAPULAR 8 0.0004
892 DYSPNOEA 200 0.0004
893 RASH PRURITIC 19 0.0004
894 CONFUSIONAL STATE 56 0.0003
895 LUNG NEOPLASM MALIGNANT 14 0.0003
896 ARRHYTHMIA 16 0.0003
897 RHABDOMYOLYSIS 14 0.0003
898 WITHDRAWAL SYNDROME 14 0.0003
899 DIABETIC KETOACIDOSIS 8 0.0003
900 TREMOR 55 0.0003
901 MUSCULAR WEAKNESS 37 0.0003
902 NECK PAIN 18 0.0003
903 OROPHARYNGEAL PAIN 29 0.0003
904 LACTIC ACIDOSIS 10 0.0003
905 ERYTHEMA 63 0.0003
906 LOSS OF CONSCIOUSNESS 39 0.0003
907 BRADYCARDIA 16 0.0003
908 EYE PAIN 17 0.0003
909 RASH 128 0.0003
910 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
911 ILL-DEFINED DISORDER 17 0.0003
912 DRY MOUTH 22 0.0003
913 SKIN DISORDER 9 0.0003
914 PREMATURE BABY 8 0.0003
915 DISTURBANCE IN ATTENTION 14 0.0003
916 BLOOD PRESSURE DECREASED 17 0.0003
917 HYPOACUSIS 11 0.0003
918 ASTHENIA 96 0.0003
919 DEHYDRATION 34 0.0003
920 ABNORMAL BEHAVIOUR 10 0.0003
921 VISUAL IMPAIRMENT 31 0.0002
922 NIGHT SWEATS 8 0.0002
923 HEADACHE 154 0.0002
924 CHOLELITHIASIS 8 0.0002
925 ALOPECIA 46 0.0002
926 BLISTER 13 0.0002
927 PARAESTHESIA 34 0.0002
928 SINUSITIS 22 0.0002
929 COGNITIVE DISORDER 10 0.0002
930 MOBILITY DECREASED 15 0.0002
931 PAIN 128 0.0002
932 CHEST PAIN 38 0.0002
933 BONE PAIN 12 0.0002
934 VERTIGO 12 0.0002
935 LETHARGY 11 0.0002
936 PANCREATITIS 10 0.0002
937 HALLUCINATION 14 0.0002
938 CHEST DISCOMFORT 19 0.0002
939 WHEEZING 11 0.0002
940 TREATMENT NONCOMPLIANCE 10 0.0002
941 BACK PAIN 42 0.0002
942 EYE IRRITATION 10 0.0002
943 FATIGUE 135 0.0002
944 SPEECH DISORDER 9 0.0002
945 DIABETES MELLITUS 13 0.0002
946 IRRITABILITY 10 0.0002
947 ABDOMINAL PAIN UPPER 34 0.0002
948 DYSGEUSIA 12 0.0002
949 HYPOAESTHESIA 24 0.0002
950 AGGRESSION 8 0.0002
951 WEIGHT DECREASED 44 0.0002
952 MATERNAL EXPOSURE DURING PREGNANCY 14 0.0002
953 DYSPHONIA 9 0.0002
954 MUSCULOSKELETAL PAIN 8 0.0002
955 VISION BLURRED 20 0.0001
956 NO ADVERSE EVENT 26 0.0001
957 SLEEP DISORDER 10 0.0001
958 GAIT DISTURBANCE 27 0.0001
959 INTENTIONAL PRODUCT MISUSE 12 0.0001
960 PRURITUS 52 0.0001
961 INSOMNIA 36 0.0001
962 ARTHRALGIA 56 0.0001
963 CONSTIPATION 29 0.0001
964 MALAISE 56 0.0001
965 ARTHRITIS 10 0.0001
966 INFUSION RELATED REACTION 8 0.0001
967 PALPITATIONS 14 0.0001
968 UNEVALUABLE EVENT 9 0.0001
969 HYPERHIDROSIS 15 0.0001
970 MUSCLE SPASMS 20 0.0001
971 HYPERSENSITIVITY 20 0.0001
972 CEREBROVASCULAR ACCIDENT 18 0.0001
973 DRY SKIN 14 0.0001
974 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
975 SOMNOLENCE 20 0.0001
976 ADVERSE EVENT 9 0.0001
977 CARDIAC DISORDER 9 0.0001
978 FALL 31 0.0001
979 PAIN IN EXTREMITY 27 0.0001
980 DIZZINESS 38 0.0001
981 MYOCARDIAL INFARCTION 13 0.0001
982 ANXIETY 21 0.0001
983 MYALGIA 12 0.0001
984 BLOOD PRESSURE INCREASED 10 0.0001
985 OVERDOSE 13 0.0001
986 DEPRESSION 12 0.0001
987 NASOPHARYNGITIS 9 0.0000
988 ABDOMINAL DISCOMFORT 8 0.0000
989 FEELING ABNORMAL 11 0.0000